FR2270853A1 - - Google Patents

Info

Publication number
FR2270853A1
FR2270853A1 FR7515190A FR7515190A FR2270853A1 FR 2270853 A1 FR2270853 A1 FR 2270853A1 FR 7515190 A FR7515190 A FR 7515190A FR 7515190 A FR7515190 A FR 7515190A FR 2270853 A1 FR2270853 A1 FR 2270853A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7515190A
Other languages
French (fr)
Other versions
FR2270853B1 (https=
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maggioni and C SpA
Original Assignee
Maggioni and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maggioni and C SpA filed Critical Maggioni and C SpA
Publication of FR2270853A1 publication Critical patent/FR2270853A1/fr
Application granted granted Critical
Publication of FR2270853B1 publication Critical patent/FR2270853B1/fr
Expired legal-status Critical Current

Links

FR7515190A 1974-05-15 1975-05-15 Expired FR2270853B1 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2270974 1974-05-15

Publications (2)

Publication Number Publication Date
FR2270853A1 true FR2270853A1 (https=) 1975-12-12
FR2270853B1 FR2270853B1 (https=) 1978-09-08

Family

ID=11199496

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7515190A Expired FR2270853B1 (https=) 1974-05-15 1975-05-15

Country Status (4)

Country Link
JP (1) JPS5123248A (https=)
DE (1) DE2521113A1 (https=)
FR (1) FR2270853B1 (https=)
GB (1) GB1461240A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482956A1 (fr) * 1980-05-22 1981-11-27 Synthelabo Cyclohexylalkylamines, leurs procedes de preparation et leur application en therapeutique

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
CA2495962A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482956A1 (fr) * 1980-05-22 1981-11-27 Synthelabo Cyclohexylalkylamines, leurs procedes de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JPS5123248A (en) 1976-02-24
GB1461240A (en) 1977-01-13
FR2270853B1 (https=) 1978-09-08
DE2521113A1 (de) 1976-03-18

Similar Documents

Publication Publication Date Title
FR2270853B1 (https=)
AU495841B2 (https=)
AR199089A1 (https=)
AR198563A1 (https=)
AR197698Q (https=)
BG20147A1 (https=)
AU479758A (https=)
AU479802A (https=)
AU479870A (https=)
AU480209A (https=)
AU480227A (https=)
AU480663A (https=)
AU480819A (https=)
AU481101A (https=)
AU481296A (https=)
AU481597A (https=)
AU481723A (https=)
AU481825A (https=)
AU481871A (https=)
AU482022A (https=)
AU482114A (https=)
AU482206A (https=)
AU482272A (https=)
AU482286A (https=)
AU482307A (https=)

Legal Events

Date Code Title Description
ST Notification of lapse